Bone marrow failure in children with acute liver failure

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 5, 2000, Pages 557-561

  Tung, John ^a,b   Hadzic, Nedim ^a   Layton, Mark ^a   Baker, Alastair J ^a   Dhawan, Anil ^a   Rela, Mohamed ^a   Heaton, Nigel D ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Acute liver failure; Aplastic anemia; Hepatitis; Parvovirus B19

Indexed keywords

LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CHILD; DRUG TOLERABILITY; ERYTHEMA INFECTIOSUM; FEMALE; GRAFT REJECTION; GRANULOPOIESIS; HEPATITIS NON A NON B; HUMAN; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PARVOVIRUS; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER FAILURE, ACUTE; MALE; PARVOVIRUS B19, HUMAN; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

NON-A, NON-B HEPATITIS VIRUS; PARVOVIRUS;

EID: 0033664895     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200011000-00019     Document Type: Article

References (39)

1. Panmyelopathienach hepatitis epidemica
2. K voprosu obizmenenii krovetvoreniia pri zabolevaniiakh pecheni
3. Aplastic anemia following viral hepatitis: Report of two fatal cases and literature review
4. Posthepatitic severe aplastic anemia - An indication for early bone marrow transplantation
5. The treatment of severe acquired aplastic anemia
6. Improved prognosis for acquired aplastic anaemia
7. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA working party
8. Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation
9. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
10. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party
11. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia
12. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature
13. Fulminant hepatic failure: Pediatric aspects
14. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
15. Early indicators of prognosis in fulminant hepatic failure
16. Incidence of aplastic anemia in viral hepatitis in children
17. Aplastic anemia: Part I. Incidence and aetiology
18. Aplastic anemia after liver transplantation for fulminant liver failure
19. Aplastic anaemia. Part III. Aplastic anaemia and infectious hepatitis
20. Aplastic anaemia complicating hepatitis A virus infection
21. A case of aplastic anaemia associated with fulminant hepatitis B
22. Aplastic anemia and viral hepatitis: Non-A, non-B, non-C?
23. Aplastic anemia and hepatitis C: Molecular biology exonerates another suspect
24. Hepatitis-associated aplastic anemia
25. Hepatitis-associated aplastic anemia
26. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)
27. Human parvovirus B19 infection associated with acute hepatitis
28. Liver dysfunction caused by parvovirus B19
29. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection
30. Human parvovirus B19 infection and hepatitis
31. Fortnightly Review: Parvovirus B19: An expanding spectrum of disease
32. The pathophysiology of acquired aplastic anemia
33. Bone marrow graft in man after conditioning by antilymphocytic serum
34. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
35. One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children
36. Myelodysplastic syndrome and pancytopenia in a patient with non-A, non-B chronic active hepatitis
37. Occurrence of myeloproliferative disorder in patients with Noonan syndrome
38. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria
39. Could aplastic anaemia be considered a pre-pre-leukaemic disorder?